Home Cart Sign in  
Chemical Structure| 1404437-62-2 Chemical Structure| 1404437-62-2

Structure of ML281
CAS No.: 1404437-62-2

Chemical Structure| 1404437-62-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML281 is a potent and selective quinoxalinone-based STK33 inhibitor with an IC50 value of 14nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML281

CAS No. :1404437-62-2
Formula : C22H19N3O2S
M.W : 389.47
SMILES Code : O=C1NC2=CC=CC=C2N=C1C3=CC(C(C)C)=CC=C3NC(C4=CC=CS4)=O
MDL No. :MFCD25976601
InChI Key :HWOYIOLMBQSTQS-UHFFFAOYSA-N
Pubchem ID :53377448

Safety of ML281

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of ML281

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
LO2 cells 10 μM 48 hours Inhibited STK33-mediated HPD T382 phosphorylation and increased HPD expression PMC6753076
U937 up to 10 μM Test the effect of ML281 on KRAS-independent cell lines, showing no significant effect on cell viability PMC3523537
THP-1 up to 10 μM Test the effect of ML281 on KRAS-independent cell lines, showing no significant effect on cell viability PMC3523537
SKM-1 up to 10 μM Test the effect of ML281 on KRAS-dependent cell lines, showing no significant effect on cell viability PMC3523537
NOMO-1 up to 10 μM Test the effect of ML281 on KRAS-dependent cell lines, showing no significant effect on cell viability PMC3523537

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Ttc36−/− mice In vitro treatment 10 μM 48 hours Inhibited STK33-mediated HPD T382 phosphorylation and increased HPD expression PMC6753076

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.84mL

2.57mL

1.28mL

25.68mL

5.14mL

2.57mL

References

 

Historical Records

Categories